Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Multiple Sclerosis and PVT1[original query] |
---|
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci. Pharmacogenomics 2017 Nov . Kulakova Olga, Bashinskaya Vitalina, Kiselev Ivan, Baulina Natalia, Tsareva Ekaterina, Nikolaev Ruslan, Kozin Maxim, Shchur Sergey, Favorov Alexander, Boyko Alexey, Favorova Ol |
[Variability of the MIR196A2 Gene as a Risk Factor in Primary-Progressive Multiple Sclerosis Development]. Molekuliarnaia biologiia 2019 5 53 (2): 282-289. Kiselev I S, Kulakova O G, Baulina N M, Bashinskaya V V, Popova E V, Boyko A N, Favorova O |
Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians. Acta naturae 0 10 (4): 79-86. Kozin M S, Kulakova O G, Kiselev I S, Balanovsky O P, Boyko A N, Favorova O |
[The analysis of association between multiple sclerosis and genetic markers identified in genome-wide association studies]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2020 8 120 (7. Vyp. 2): 54-60. Timasheva Y R, Nasibullin T R, Tuktarova I A, Erdman V V, Galiullin T R, Zaplakhova O V, Bakhtiiarova K Z, Mustafina O |
Mitonuclear interactions influence multiple sclerosis risk. Gene 2020 Jul 144962. Kozin Maxim, Kulakova Olga, Kiselev Ivan, Baulina Natalia, Boyko Alexey, Favorova Ol |
[Risk of Multiple Sclerosis: Analysis of Interactions Between Variants of Nuclear and Mitochondrial Genomes]. Molekuliarnaia biologiia 0 55 (6): 956-964. Kozin M S, Kiselev I S, Baulina N M, Pavlova G V, Boyko A N, Kulakova O G, Favorova O |
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of personalized medicine 2021 Oct 11 (10): . Zarzuelo-Romero María José, Pérez-Ramírez Cristina, Cura Yasmín, Carrasco-Campos María Isabel, Marangoni-Iglecias Luciana María, Ramírez-Tortosa María Carmen, Jiménez-Morales Alber |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: